<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJPed</journal-id><journal-title-group><journal-title>Open Journal of Pediatrics</journal-title></journal-title-group><issn pub-type="epub">2160-8741</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojped.2024.141015</article-id><article-id pub-id-type="publisher-id">OJPed-130734</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Epidemiological, Clinical Aspects and Outcome of Measles in a Low-Income Country in 2023
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sime</surname><given-names>Tchouamo Arielle Annick</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Enyama</surname><given-names>Dominique</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Noukeu</surname><given-names>Diomède</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Atyam</surname><given-names>Ekotto Marie Christine</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Abouame</surname><given-names>Palma Haoua</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Epee</surname><given-names>Ngoue Jeannette</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kago</surname><given-names>Tague Daniel Armand</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Touka</surname><given-names>Eric Brice</given-names></name><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Tasse</surname><given-names>Simo Nathalie Ines</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Nguéfack</surname><given-names>Félicité</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib></contrib-group><aff id="aff7"><addr-line>West Regional Delegation of Public Health, Bafoussam, Cameroon</addr-line></aff><aff id="aff4"><addr-line>Regional Annex Hospital of Dschang, Dschang, Cameroon</addr-line></aff><aff id="aff2"><addr-line>Faculty of Medicine and Pharmaceutical Sciences of University of Dschang, Dschang, Cameroon</addr-line></aff><aff id="aff3"><addr-line>Gynaeco-Obstetric and Pediatric Hospital of Douala, Douala, Cameroon</addr-line></aff><aff id="aff5"><addr-line>Faculty of Medicine and Biomedical Sciences of University of Garoua, Garoua, Cameroon</addr-line></aff><aff id="aff1"><addr-line>Gynaeco-Obstetric and Pediatric Hospital of Yaounde, Yaounde, Cameroon</addr-line></aff><aff id="aff6"><addr-line>Faculty of Medicine and Biomedical Sciences of University of Yaounde 1, Yaounde, Cameroon</addr-line></aff><pub-date pub-type="epub"><day>04</day><month>01</month><year>2024</year></pub-date><volume>14</volume><issue>01</issue><fpage>139</fpage><lpage>148</lpage><history><date date-type="received"><day>15,</day>	<month>November</month>	<year>2023</year></date><date date-type="rev-recd"><day>23,</day>	<month>January</month>	<year>2024</year>	</date><date date-type="accepted"><day>26,</day>	<month>January</month>	<year>2024</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Introduction: Measles remains a worrying health problem in sub-Saharan African countries. There have been measles outbreaks in Cameroon with the most recent occurring between October 2022 and September 2023. The Centre region of Cameroon was the most affected in the country and being at the frontline of the fight against this illness, we conducted this study in order to determine the epidemiological and clinical characteristics as well as the outcome of children who contracted the measles and were hospitalized at the Yaound&#233; Gynaeco-Obstetric and Pediatric Hospital. Methodology: We conducted a cross-sectional descriptive and prospective study for one year from October 2022 to November 2023 corresponding to the duration of the outbreak. We included all children admitted in the pediatric unit for measles and its complications during this period. Results
  :
   In total, 60 children were enrolled. Their caregivers were mostly their mothers who had a mean age of 34.71 &#177; 9.55 years living in significant precarious conditions for the majority. The median age of children was 16 months (09 
  -
   30 months).
   
  Twenty six percent of children (16) were less than 9 months. Girls were predominant (55%). Most children were not up to date with their routine EPI vaccination (80%) and most did not receive the measles and Rubella vaccine (76.67%). Clinical manifestations, included fever, conjunctivitis, and cough. Skin rash and catarrh (98.33% and 86.67% respectively) are the case definition signs of measles. The outcome was unfavorable for 4 children. One had a neurological disorder: coma and three presented with pneumonia and severe respiratory distress (6.67%). Conclusion: Measles 
  is 
  still being a reality and claiming lives in our context, emphasis should 
  be 
  made on immunization coverage and if possible, advocacies should 
  be 
  formulated to decrease the age of measles vaccine administration.
 
</p></abstract><kwd-group><kwd>Measles</kwd><kwd> Complications</kwd><kwd> Low-Income Countries</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Measles is a highly contagious disease caused by the measles virus which belongs to the Paramyxoviridae family [<xref ref-type="bibr" rid="scirp.130734-ref1">1</xref>] . Measles can affect everyone but it is most common in children [<xref ref-type="bibr" rid="scirp.130734-ref2">2</xref>] . It is characterized by fever, cough and skin rashes and it can lead to severe complications such as otitis, pneumonia, encephalitis, which can lead to death [<xref ref-type="bibr" rid="scirp.130734-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.130734-ref4">4</xref>] . Having humans as the only reservoir and with the existence of a vaccine, strategies have been put in place to eradicate the illness since 1963 [<xref ref-type="bibr" rid="scirp.130734-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.130734-ref5">5</xref>] . For 16 years, there has been no endemic measles in the United States. However WHO-Afro zones and some European countries continued to be affected by outbreaks of this illness [<xref ref-type="bibr" rid="scirp.130734-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.130734-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.130734-ref7">7</xref>] . In sub Saharan Africa, measles continues to be an important public health problem due to the frequent occurrence of complications in children [<xref ref-type="bibr" rid="scirp.130734-ref8">8</xref>] . In 2021, an estimate of 128,000 people died of measles according to WHO reports. Most of these were children [<xref ref-type="bibr" rid="scirp.130734-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.130734-ref2">2</xref>] . In 2012 a global vaccine action plan approved by the WHO assembly set a goal for measles and rubella elimination by 2020 in at least 5 of the 6 WHO zones [<xref ref-type="bibr" rid="scirp.130734-ref3">3</xref>] . However there have been reports of outbreaks in China from 2015 to 2016, in the Philippines and Greece from 2018 to 2019 and recently in the WHO-Afro zones such as Democratic Republic of the Congo in 2019, Nigeria in 2020 and Cameroon in 2020 [<xref ref-type="bibr" rid="scirp.130734-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.130734-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.130734-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.130734-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.130734-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.130734-ref12">12</xref>] . Therefore, the goal of the 2012 global plan for eradication of measles and rubella is far from being achieved. WHO and UNICEF noted an increase in February 2022 in the number of measles cases and the risk of larger outbreaks [<xref ref-type="bibr" rid="scirp.130734-ref13">13</xref>] . Sub-optimal vaccinal coverage and pandemic disruption are the main reasons for these outbreaks [<xref ref-type="bibr" rid="scirp.130734-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.130734-ref13">13</xref>] . Symptoms of measles include fever, maculopapular skin rash, cough, coryza, conjuntivitis and we can have the Koplik’s spot which appears 1 or 2 days before the rash [<xref ref-type="bibr" rid="scirp.130734-ref7">7</xref>] .</p><p>Complications of measles include pneumonia, tracheitis, diarrhea, superimposed bacterial infections, subacute sclerosing panencephalitis and death. These complications are most common in young infants who are immunocompromised or undernourished particularly children with vitamin A deficiency [<xref ref-type="bibr" rid="scirp.130734-ref7">7</xref>] .</p><p>In Cameroon, measles outbreak is still raging with the Centre region being the most affected [<xref ref-type="bibr" rid="scirp.130734-ref11">11</xref>] . The viral PCR test to confirm the measles was done for the first cases at the beginning of the outbreaks. It is under this context that we conducted a study during the most recent outbreak (2022 to 2023), which aimed at describing the epidemiological, clinical aspects and outcome of children affected by measles and hospitalised at the Gynaeco-Obstetric and Pediatric Hospital of Yaounde.</p></sec><sec id="s2"><title>2. Methodology</title><p>We conducted a hospital based cross-sectional descriptive and prospective study at the Gynaeco-Obstetric and Pediatric Hospital of Yaounde (YGOPH). It is a first category health facility on the health pyramid of Cameroon, specialized in mother and child healthcare. It is located in the city of Yaounde in the center region, making it a reference facility for the management of measles. Our study lasted for one year from October 1 2022 to September 30 2023 during the most recent Measles outbreak. We used a consecutive sampling. Every child hospitalized for measles at the YGOPH during the study period were included in our study.</p><p>After obtaining an ethical clearance and authorizations from the parents, we collected data using a questionnaire administered to parents and the children, we observed and collected data on the clinical manifestations, complications and outcome.</p><p>Variables of interest included sociodemographic characteristics of children included caregiver: age, monthly revenue, level of education; concerning children: age, sex, nutritional status, clinical manifestations of measles, complications and outcome.</p><p>Data was entered and analyzed using EPIINFO 7.2.5.0.</p></sec><sec id="s3"><title>3. Results</title><p>During our study period, 60 children were admitted and followed up for measles for a median duration of 4 days with the maximum hospitalization duration being 10 days. The main caregiver was the mother (60%), most of them were less than 40 years old (73.33%) with a mean age of 34.71 years. The majority worked in the informal sector (85%) with a monthly salary of less than 50,000 FCFA for most of them (60%). The highest level of education reported was secondary level (53.33%). Most parents were cohabitating (44.19%) and the majority of them resided in Yaound&#233; (86.67%). <xref ref-type="table" rid="table1">Table 1</xref>.</p><p>The median age of children was 16 months (09 - 30 months) with a majority of them being less than 2 years old (71.67%). There were 5 children less than 6 months (8.33%), 11 (18.33%) children aged from 6 to nine months. Girls were predominant (55%) and only one child was orphan (01.67%). Most children were not up to date with their routine EPI vaccination (80%) and most did not receive the measles and Rubella vaccine (76.67%). However, the majority of children received Vitamin A supplementation (65%). <xref ref-type="table" rid="table2">Table 2</xref>.</p><p>Regarding the clinical manifestations, everyone presented fever, conjunctivitis, and cough. Most presented skin rash and catarrh (98.33% and 86.67% respectively), which are the case definition signs of measles. Other clinical manifestations were reported and their frequencies can be observed in <xref ref-type="table" rid="table3">Table 3</xref>. We recorded 29 children (48.33%) who had pneumonia, Fifteen percent of our patients convulsed.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Socio demographic characteristics of caregiver</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"   rowspan="2"  >Characteristics</th><th align="center" valign="middle" >Frequency (N = 60)</th><th align="center" valign="middle" >Pourcentage</th></tr></thead><tr><td align="center" valign="middle" >n</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Caregiver</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Mother</td><td align="center" valign="middle" >36</td><td align="center" valign="middle" >60.00</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Father</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >33.33</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Others</td><td align="center" valign="middle" >04</td><td align="center" valign="middle" >06.67</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Mean age &#177; SD: 34.71 &#177; 9.55 Years</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="2"  >Age of care giver (years)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >19 - 29</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >30.00</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >30 - 39</td><td align="center" valign="middle" >26</td><td align="center" valign="middle" >43.33</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >40 - 49</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >20.00</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >50 - 59</td><td align="center" valign="middle" >02</td><td align="center" valign="middle" >03.33</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >60 - 67</td><td align="center" valign="middle" >02</td><td align="center" valign="middle" >03.33</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Profession</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Formal</td><td align="center" valign="middle" >09</td><td align="center" valign="middle" >15.00</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Informal</td><td align="center" valign="middle" >51</td><td align="center" valign="middle" >85.00</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Monthly Revenue (Francs CFA)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >0 - 50,000</td><td align="center" valign="middle" >36</td><td align="center" valign="middle" >60.00</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >50,000 - 100,000</td><td align="center" valign="middle" >17</td><td align="center" valign="middle" >28.33</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >100,000 - 200,000</td><td align="center" valign="middle" >02</td><td align="center" valign="middle" >03.33</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >+200,000</td><td align="center" valign="middle" >05</td><td align="center" valign="middle" >08.33</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Level of education</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >None</td><td align="center" valign="middle" >04</td><td align="center" valign="middle" >06.67</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Primary</td><td align="center" valign="middle" >08</td><td align="center" valign="middle" >13.33</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Secondary</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >53.33</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >University</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >26.67</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Marital statut</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Single</td><td align="center" valign="middle" >08</td><td align="center" valign="middle" >18.60</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Cohabitation</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >44.19</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Divorce</td><td align="center" valign="middle" >02</td><td align="center" valign="middle" >04.65</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Marriage</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >30.23</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Widowhood</td><td align="center" valign="middle" >01</td><td align="center" valign="middle" >02.33</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Residence</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >In Yaounde</td><td align="center" valign="middle" >52</td><td align="center" valign="middle" >86.67</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Out of Yaounde</td><td align="center" valign="middle" >08</td><td align="center" valign="middle" >13.33</td></tr></tbody></table></table-wrap><p>Concerning the nutritional status of our children, 10 children (16.67%) presented an acute malnutrition with one presenting a kwashiorkor. Fifteen percent were underweight for their age. <xref ref-type="table" rid="table3">Table 3</xref>.</p><p>Concerning the outcome, it was favourable in 93.3% (56). Four deaths due to measles complications (06.67%) were noted. The children who died were aged from 6 to 24 months. One had a neurological disorder: coma, three had pneumonia with severe respiratory distress. <xref ref-type="table" rid="table4">Table 4</xref>.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Characteristics of children</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"   rowspan="2"  >Characteristics</th><th align="center" valign="middle" >Frequency (N = 60)</th><th align="center" valign="middle" >Percentage</th></tr></thead><tr><td align="center" valign="middle" >n</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Median age (Q1 - Q3): 16 (09 - 30) Months</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="2"  >Age of children Months</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="2"  >0 - 5</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >8.33</td></tr><tr><td align="center" valign="middle"  colspan="2"  >6 - 9</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >18.33</td></tr><tr><td align="center" valign="middle"  colspan="2"  >10 - 23</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >45</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >≤ 24</td><td align="center" valign="middle" >43</td><td align="center" valign="middle" >71.67</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >&gt;24 - 48</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >25.00</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >&gt;48 - 72</td><td align="center" valign="middle" >01</td><td align="center" valign="middle" >01.67</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >&gt;72</td><td align="center" valign="middle" >01</td><td align="center" valign="middle" >01.67</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Sex of children</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Girls</td><td align="center" valign="middle" >33</td><td align="center" valign="middle" >55.00</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Boys</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >45.00</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Orphan</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Parents alive</td><td align="center" valign="middle" >59</td><td align="center" valign="middle" >98.33</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Orphaned</td><td align="center" valign="middle" >01</td><td align="center" valign="middle" >01.67</td></tr><tr><td align="center" valign="middle"  colspan="2"  >EPI Vaccination up to date</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >48</td><td align="center" valign="middle" >80.00</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >20.00</td></tr><tr><td align="center" valign="middle"  colspan="2"  >RR received</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >46</td><td align="center" valign="middle" >76.67</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >23.33</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Vitamin A received</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >35.00</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >39</td><td align="center" valign="middle" >65.00</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Clinical manifestation</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"   rowspan="3"  >Measles disorder</th><th align="center" valign="middle"  colspan="4"  >Investigated children N = 60</th></tr></thead><tr><td align="center" valign="middle"  colspan="2"  >Present</td><td align="center" valign="middle"  colspan="2"  >Absent</td></tr><tr><td align="center" valign="middle" >n</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >n</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle"  colspan="2"  >General state disorder</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Fever</td><td align="center" valign="middle" >60</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >00</td><td align="center" valign="middle" >00.00</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Dehydration</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >23.33</td><td align="center" valign="middle" >46</td><td align="center" valign="middle" >76.67</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Acute Malnutrition</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >16.67</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >83.33</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Chronic malnutrition</td><td align="center" valign="middle" >04</td><td align="center" valign="middle" >06.67</td><td align="center" valign="middle" >56</td><td align="center" valign="middle" >93.33</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Under Weight</td><td align="center" valign="middle" >09</td><td align="center" valign="middle" >15.00</td><td align="center" valign="middle" >51</td><td align="center" valign="middle" >85.00</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Ocular disorder</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Conjunctivitis</td><td align="center" valign="middle" >60</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >00</td><td align="center" valign="middle" >00.00</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Skin disorder</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Skin rash</td><td align="center" valign="middle" >59</td><td align="center" valign="middle" >98.33</td><td align="center" valign="middle" >01</td><td align="center" valign="middle" >01.67</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Pruritus</td><td align="center" valign="middle" >06</td><td align="center" valign="middle" >10.00</td><td align="center" valign="middle" >54</td><td align="center" valign="middle" >90.00</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Enanthema</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >41.67</td><td align="center" valign="middle" >35</td><td align="center" valign="middle" >58.33</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Respiratory tract disorder</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Cough</td><td align="center" valign="middle" >60</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >00</td><td align="center" valign="middle" >00.00</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Laryngitis</td><td align="center" valign="middle" >06</td><td align="center" valign="middle" >10.00</td><td align="center" valign="middle" >54</td><td align="center" valign="middle" >90.00</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Catarrh</td><td align="center" valign="middle" >52</td><td align="center" valign="middle" >86.67</td><td align="center" valign="middle" >08</td><td align="center" valign="middle" >13.33</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Pneumonia</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >48.33</td><td align="center" valign="middle" >31</td><td align="center" valign="middle" >51.67</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Pleural effusion</td><td align="center" valign="middle" >01</td><td align="center" valign="middle" >01.67</td><td align="center" valign="middle" >59</td><td align="center" valign="middle" >98.33</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Purulent otitis</td><td align="center" valign="middle" >01</td><td align="center" valign="middle" >01.67</td><td align="center" valign="middle" >59</td><td align="center" valign="middle" >98.33</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Digestive tract disorders</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Nausea</td><td align="center" valign="middle" >01</td><td align="center" valign="middle" >01.67</td><td align="center" valign="middle" >59</td><td align="center" valign="middle" >98.33</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Vomiting</td><td align="center" valign="middle" >23</td><td align="center" valign="middle" >38.33</td><td align="center" valign="middle" >37</td><td align="center" valign="middle" >61.67</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Abdominal pain</td><td align="center" valign="middle" >01</td><td align="center" valign="middle" >01.67</td><td align="center" valign="middle" >59</td><td align="center" valign="middle" >98.33</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Diarrhoea</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >36.67</td><td align="center" valign="middle" >38</td><td align="center" valign="middle" >63.33</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Neurological disorder</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Convulsion</td><td align="center" valign="middle" >09</td><td align="center" valign="middle" >15.00</td><td align="center" valign="middle" >51</td><td align="center" valign="middle" >85.00</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Coma</td><td align="center" valign="middle" >03</td><td align="center" valign="middle" >05.00</td><td align="center" valign="middle" >57</td><td align="center" valign="middle" >95.00</td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Outcome of Measles in the study population</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"  >Evolution</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percentage</th></tr></thead><tr><td align="center" valign="middle"  colspan="2"  >Median admission duration: 4 days (3 - 6) days</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="2"  >Admission duration</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >≤4 days</td><td align="center" valign="middle" >37</td><td align="center" valign="middle" >61.67</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >&gt;4 days</td><td align="center" valign="middle" >23</td><td align="center" valign="middle" >38.33</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Outcome</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Favourable</td><td align="center" valign="middle" >56</td><td align="center" valign="middle" >93.33</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Unfavourable</td><td align="center" valign="middle" >04</td><td align="center" valign="middle" >6.67</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Circumstances of death</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Coma</td><td align="center" valign="middle" >01</td><td align="center" valign="middle" >25</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Severe Respiratory distress</td><td align="center" valign="middle" >03</td><td align="center" valign="middle" >75</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Deaths</td><td align="center" valign="middle" >04</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap></sec><sec id="s4"><title>4. Discussion</title><p>Cameroon is facing an outbreak of measles. According to the report of the center of emergencies of Cameroon on the 26 November 2023, 6054 cases of measles were confirmed with 31 deaths due to measles since the beginning of the year 2023 and the Center region is the most affected. Knowing that measles can lead to complication that can end up being fatal, we studied the epidemiological and clinical characteristics of children who were hospitalized for measles at gynaeco-obstetric and pediatric hospital of Yaounde in the center region, which is a reference center.</p><p>We collected 60 cases of measles who were hospitalized. Knowing that all non-complicated cases were treated at home.</p><p>Our data confirm that measles continues to be an important public health problem and especially during epidemics causes significant morbidity and complications.</p><p>Concerning our patients hospitalized, most of their parents lived in a significant level of precariousness (60%) and this could explain the exposure of their children to measles. Because measles is a highly contagious disease.</p><p>Most children (71.67%) affected were aged below two years, 16 children (26.6%) affected were less than 9 months. we noticed five (8.33%) less than 6 months and these findings were similar to those reported by Domai et al. in Philippines [<xref ref-type="bibr" rid="scirp.130734-ref9">9</xref>] and Gianniki in Greece [<xref ref-type="bibr" rid="scirp.130734-ref12">12</xref>] or Sindhu in India [<xref ref-type="bibr" rid="scirp.130734-ref14">14</xref>] . Those cases of children aged less than 6 months were relevant.</p><p>This could be explained by the vaccination policies in Cameroon, which target 9 months to start vaccination against measles. It is expected that maternal measles IgG antibodies cover children below these ages. It would be relevant to start vaccination earlier as illustrated by Martins et al. in Guinea-Bissau [<xref ref-type="bibr" rid="scirp.130734-ref15">15</xref>] . Maybe the beginning of vaccination at 6 months or less can help to reduce the cases for the population of 6 - 9 months. Advocacies towards partners should be done to reduce the age of administration of measles and rubella vaccines.</p><p>There was a predominance of girls in our study and this could be explaining by the predominance female population in our context. These findings did not concord with those reported by Gianniki et al. in Greece, who found no sex related difference, Boushab et al. in Mauritania and Wang et al. in China where boys where predominant. For the latter this difference could be explained by the context too, where boys population are predominant [<xref ref-type="bibr" rid="scirp.130734-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.130734-ref8">8</xref>] .</p><p>It should be noted that most affected children (80%) were not up to date with their EPI immunization status as well as with their Measles and Rubella vaccination status (76.67%). This could be explained by the fact that we have a low immunization coverage of routine EPI vaccines. Or vaccination is free of charge in our country. Intensive community sensitization has to be done to understand why parents are not bringing children to vaccination and to encourage parents to take their children for vaccination following EPI calendar.</p><p>Regarding their clinical manifestations, most of them presented with the case definition signs of measles (body rash, conjunctivitis, cough and catarrh) and the enanthema was found in 41.67% of our study population. Respiratory disorders represented the main accompanying manifestations with pneumonia being the leading manifestation. these results concord the findings reported by Sindhu et al. in India [<xref ref-type="bibr" rid="scirp.130734-ref16">16</xref>] , Hassan et al. in Somalia [<xref ref-type="bibr" rid="scirp.130734-ref17">17</xref>] Boushab et al. in Mauritania [<xref ref-type="bibr" rid="scirp.130734-ref8">8</xref>] Domai et al. in the Philippines [<xref ref-type="bibr" rid="scirp.130734-ref9">9</xref>] . This is explained by the early targets of the virus which are the alveolar macrophages and the dendritic cells located in the lungs [<xref ref-type="bibr" rid="scirp.130734-ref1">1</xref>] .</p><p>Concerning the Outcome, it was unfavorable for 4 cases (6.67%). Their complications were marked by Coma, for one case, severe respiratory distress for three. The reported fatality rate was similar to the findings of Boushab et al. in Mauritania who reported a fatality rate of 8% [<xref ref-type="bibr" rid="scirp.130734-ref8">8</xref>] . However, it was higher than that reported by Hassan et al. in Somalia who found a fatality rate of 1.8% [<xref ref-type="bibr" rid="scirp.130734-ref17">17</xref>] . This shows that measles cases need to be detected early and managed adequately especially in our context.</p></sec><sec id="s5"><title>5. Weakness</title><p>Our study was done in only one hospital therefore the generalization of our results should be taken with caution.</p></sec><sec id="s6"><title>6. Conclusion</title><p>Measles remains a reality, and continues to claim children’s lives in our context. The 2022 to 2023 outbreak clearly shows that the goal of elimination of measles in 2020 was not achieved. Therefore, there is an urgent need to review strategies put in place. Studies should be done to determine the duration of maternal protection of children against measles and advocacies should be formulated to reduce the age of vaccination against measles.</p></sec><sec id="s7"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s8"><title>Cite this paper</title><p>Annick, S.T.A., Dominique, E., Diom&#232;de, N., Christine, A.E.M., Haoua, A.P., Jeannette, E.N., Armand, K.T.D., Brice, T.E., Ines, T.S.N. and F&#233;licit&#233;, N. (2024) Epidemiological, Clinical Aspects and Outcome of Measles in a Low-Income Country in 2023. Open Journal of Pediatrics, 14, 139-148. https://doi.org/10.4236/ojped.2024.141015</p></sec></body><back><ref-list><title>References</title><ref id="scirp.130734-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Antona, D., Dina, J., Soing-Altrach, S., A&amp;#239;t-Belghiti, F., Georges, S., Maine, C. and Lévy-Bruhl, D. (2019) épidémiologie de la rougeole en Franceen 2011-2018. Bulletin épidémiologique Hebdomadaire, 13, 218-227.</mixed-citation></ref><ref id="scirp.130734-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Boushab, B.M., Savadogo, M., Sow, M.S. and Dao, S. (2015) Epidemiological, Clinical, and Prognostic Study of the Measles in the Aioun Regional Hospital in Mauritania. Médecine et Santé Tropicales, 25, 180-183.  
https://doi.org/10.1684/mst.2015.0447</mixed-citation></ref><ref id="scirp.130734-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Cherry, J.D. and Zahn, M. (2018) Clinical Characteristics of Measles in Previously Vaccinated and Unvaccinated Patients in California. Clinical Infectious Diseases, 67, 1315-1319. https://doi.org/10.1093/cid/ciy286</mixed-citation></ref><ref id="scirp.130734-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Domai, F.M., Agrupis, K.A., Han, S.M., Sayo, A.R., Ramirez, J.S., Nepomuceno, R., Suzuki, S., Villanueva, A.M.G., Salva, E.P., Villarama, J.B., Ariyoshi, K., Mulholland, K., Palla, L., Takahashi, K., Smith, C. and Miranda, E. (2022) Measles Outbreak in the Philippines: Epidemiological and Clinical Characteristics of Hospitalized Children, 2016-2019. The Lancet, 19, Article ID: 100334.  
https://doi.org/10.1016/j.lanwpc.2021.100334</mixed-citation></ref><ref id="scirp.130734-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Eposi, H.C. and Benjamin, K.M. (n.d.) Measles Outbreak Investigation in a Highly Vaccinated Community in the Centre Region of Cameroon. Journal of Public Health in Africa, 12, 1.</mixed-citation></ref><ref id="scirp.130734-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Gianniki, M., Siahanidou, T., Botsa, E. and Michos, A. (2021) Measles Epidemic in Pediatric Population in Greece during 2017–2018: Epidemiological, Clinical Characteristics and Outcomes. PLOS ONE, 16, e0245512.  
https://doi.org/10.1371/journal.pone.0245512</mixed-citation></ref><ref id="scirp.130734-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Hassan, M.Y., Mohamud, R.Y.H., Kassim, M.M., Hussein, A.I., Adam, M.K., Akbulut, U.E., Olum, R., Okot, J., Bongomin, F. and Ahmed, M.A.M. (2023) Clinical Characteristics and Outcomes of Patients Hospitalized with Measles during an Outbreak in Somalia. IJID Regions, 8, 31-35.  
https://doi.org/10.1016/j.ijregi.2023.05.003</mixed-citation></ref><ref id="scirp.130734-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Laksono, B., De Vries, R., McQuaid, S., Duprex, W. and De Swart, R. (2016) Measles Virus Host Invasion and Pathogenesis. Viruses, 8, 210.  
https://doi.org/10.3390/v8080210</mixed-citation></ref><ref id="scirp.130734-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Martins, C.L., Garly, M.-L., Bale, C., Rodrigues, A., Ravn, H., Whittle, H.C., Lisse, I. M. and Aaby, P. (2008) Protective Efficacy of Standard Edmonston-Zagreb Measles Vaccination in Infants Aged 4.5 Months: Interim Analysis of a Randomised Clinical Trial. BMJ, 337, a661. https://doi.org/10.1136/bmj.a661</mixed-citation></ref><ref id="scirp.130734-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">WHO (2023) Measles. https://www.who.int/news-room/fact-sheets/detail/measles</mixed-citation></ref><ref id="scirp.130734-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Muthiah, N., Galagoda, G., Handunnetti, S., Peiris, S. and Pathirana, S. (2021) Dynamics of Maternally Transferred Antibodies against Measles, Mumps, and Rubella in Infants in Sri Lanka. International Journal of Infectious Diseases, 107, 129-134.  
https://doi.org/10.1016/j.ijid.2021.04.002</mixed-citation></ref><ref id="scirp.130734-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Nomhwange, T., Mohammed, A., Jean Baptiste, A.E., Musa, A., Yusuf, A., Yusuf, M., Wagai, J., Shettima, A., Mele, S., Banda, R., Braka, F., Luce, R. and Masresha, B. (2022) Measles Outbreak Response Immunization during the COVID-19 Pandemic: Lessons from Borno State, Nigeria. Pan African Medical Journal, 41, Article 104.  
https://doi.org/10.11604/pamj.2022.41.104.28162</mixed-citation></ref><ref id="scirp.130734-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Olugbade, O.T., Adeyemi, A.S., Adeoti, H.A., Ilesanmi, O.S., Gidado, S.O., Waziri, N.E. and Aworh, M. (2019) Measles Outbreaks and Supplemental Immunization Activities (SIAs): The Gwagwalada Experience, Abuja 2015. Pan African Medical Journal, 32, Article No. 10. https://doi.org/10.11604/pamj.supp.2019.32.1.13368</mixed-citation></ref><ref id="scirp.130734-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Sindhu, T., Geeta, M., Krishnakumar, P., Sabitha, S. and Ajina, K. (2019) Clinical Profile of Measles in Children with Special Reference to Infants. Tropical Doctor, 49, 20-23. https://doi.org/10.1177/0049475518804695</mixed-citation></ref><ref id="scirp.130734-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Sodjinou, V.D., Mengouo, M.N., Douba, A., Tanifum, P., Yapi, M.D., Kuzanwa, K. R., Otomba, J.S. and Masresha, B. (2022) Epidemiological Characteristics of a Protracted and Widespread Measles Outbreak in the Democratic Republic of Congo, 2018-2020. The Pan African Medical Journal, 42, 282.</mixed-citation></ref><ref id="scirp.130734-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">WHO (2022) UNICEF and WHO Warn of Perfect Storm of Conditions for Measles Outbreaks, Affecting Children.  
https://www.who.int/news/item/27-04-2022-unicef-and-who-warn-of--perfect-storm--of-conditions-for-measles-outbreaks--affecting-children</mixed-citation></ref><ref id="scirp.130734-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Wang, X.-Y., Zhang, X.-J., Xia, X., Chang, S.-Z. and Wu, A.-Z. (2023) Epidemiological and Clinical Characteristics of Measles in Jinan, Shandong Province, China, from 1991 to 2022. International Journal of General Medicine, 16, 2305-2312.  
https://doi.org/10.2147/IJGM.S407121</mixed-citation></ref></ref-list></back></article>